The Auckland calcium study: 5-year post-trial follow-up

被引:19
作者
Radford, L. T. [1 ]
Bolland, M. J. [1 ,2 ]
Mason, B. [1 ]
Horne, A. [1 ]
Gamble, G. D. [1 ]
Grey, A. [1 ]
Reid, I. R. [1 ]
机构
[1] Univ Auckland, Dept Med, Auckland 1142, New Zealand
[2] Univ Auckland, Dept Med, Bone & Joint Res Grp, Auckland 1142, New Zealand
关键词
Bone densitometry; Calcium supplements; Fracture; Myocardial infarction; Stroke; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; HEALTHY OLDER WOMEN; VITAMIN-D; FRACTURE RISK; DOUBLE-BLIND; SUPPLEMENTATION; METAANALYSIS; MEN; WITHDRAWAL;
D O I
10.1007/s00198-013-2526-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Five years after completion of a randomised placebo-controlled trial of calcium supplements, there was no effect of calcium on total fracture incidence, a significant reduction in vertebral and forearm fractures and, in a subset, no effect on bone density. There was no increased risk of cardiovascular events after discontinuation of calcium. The Auckland calcium study was a 5-year randomised controlled trial of 1 g/day calcium citrate in 1,471 postmenopausal women. Calcium did not reduce total, vertebral or forearm fracture incidence, increased hip fracture incidence and had beneficial effects on bone mineral density (BMD). A secondary analysis raised concerns about the cardiovascular safety of calcium. The purpose of this study was to determine whether the effects of calcium on fracture incidence, BMD and cardiovascular endpoints persisted after supplement discontinuation. Approximately 5-years post-trial, we collected information on the 1,408 participants alive at trial completion from the national databases of hospital admissions and deaths. We contacted 1,174 women by phone, and from these we obtained information on medical events and post-trial calcium use. We undertook BMD measurements at 10 years in a selected subset of 194 women who took study medication for 5 years in the original trial, and did not take bone-active medications post-trial. Over the 10-year period, there was no effect on total fracture (HR 0.90, 95 % CI 0.75-1.07) or hip fracture incidence (1.40, 0.89-2.21), but significant reductions in forearm (0.62, 0.43-0.89) and vertebral fractures (0.52, 0.32-0.85) in those assigned to calcium. There were no between-group differences in BMD at 10 years at any site. The adverse cardiovascular outcomes observed in the 5-year trial did not persist post-trial. Calcium supplementation for 5 years had no effect on total fracture incidence at 10 years. The positive benefits on BMD and the adverse cardiovascular effects did not persist once supplements were stopped.
引用
收藏
页码:297 / 304
页数:8
相关论文
共 16 条
  • [1] Long-Term Follow-Up for Mortality and Cancer in a Randomized Placebo-Controlled Trial of Vitamin D3 and/or Calcium (RECORD Trial)
    Avenell, Alison
    MacLennan, Graeme S.
    Jenkinson, David J.
    McPherson, Gladys C.
    McDonald, Alison M.
    Pant, Puspa R.
    Grant, Adrian M.
    Campbell, Marion K.
    Anderson, Frazer H.
    Cooper, Cyrus
    Francis, Roger M.
    Gillespie, William J.
    Robinson, C. Michael
    Torgerson, David J.
    Wallace, W. Angus
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (02) : 614 - 622
  • [2] Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis
    Avenell, Alison
    Gillespie, William J.
    Gillespie, Lesley D.
    O'Connell, Dianne
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (02):
  • [3] Effect of calcium supplementation on fracture risk: a double-blind randomized controlled trial
    Bischoff-Ferrari, Heike A.
    Rees, Judy R.
    Grau, Maria V.
    Barry, Elizabeth
    Gui, Jiang
    Baron, John A.
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 87 (06) : 1945 - 1951
  • [4] Bischoff-Ferrari HA, 2007, AM J CLIN NUTR, V86, P1780
  • [5] Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial
    Bolland, Mark J.
    Barber, P. Alan
    Doughty, Robert N.
    Mason, Barbara
    Horne, Anne
    Ames, Ruth
    Gamble, Gregory D.
    Grey, Andrew
    Reid, Ian R.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2008, 336 (7638): : 262 - 266
  • [6] Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis
    Bolland, Mark J.
    Grey, Andrew
    Avenell, Alison
    Gamble, Greg D.
    Reid, Ian R.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
  • [7] Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis
    Bolland, Mark J.
    Avenell, Alison
    Baron, John A.
    Grey, Andrew
    MacLennan, Graeme S.
    Gamble, Greg D.
    Reid, Ian R.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2010, 341 : 289
  • [8] The skeletal benefits of calcium- and vitamin D3-fortified milk are sustained in older men after withdrawal of supplementation:: an 18-mo follow-up study
    Daly, Robin M.
    Petrass, Nicole
    Bass, Shona
    Nowson, Caryl A.
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 87 (03) : 771 - 777
  • [9] Dawson-Hughes B, 2000, AM J CLIN NUTR, V72, P745
  • [10] Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial
    Grant, AM
    Anderson, FH
    Avenell, A
    Campbell, MK
    Cooper, C
    Donaldson, C
    Francis, RM
    Gillespie, WJ
    Robinson, CM
    Torgerson, DJ
    Wallace, WA
    McPherson, GC
    MacLennan, GS
    McDonald, AM
    Grant, M
    Avenell, A
    Campbell, MK
    McDonald, AM
    MacLennan, GS
    McPherson, GC
    Anderson, FH
    Cooper, C
    Francis, RM
    Donaldson, C
    Gillespie, WJ
    Robinson, CM
    Torgerson, DJ
    Wallace, WA
    [J]. LANCET, 2005, 365 (9471) : 1621 - 1628